Monday December 12 2011

News Source: Global Disclosures

Focus: Foreign Investment

Type: General

Country: India




The Reserve Bank of India has announced that the extant India FDI policy for the pharmaceuticals sector has been reviewed, The new rules introduce the following:

(i) FDI, up to 100 per cent, under the automatic route, will continue to be permitted for green field investments in the pharmaceuticals sector.

(ii) FDI, up to 100 per cent, will be permitted for brownfield investment (i.e. investments in existing companies), in the pharmaceutical sector, under the Government approval route.

Click on the above link for more details.